EXSEL Drug Patent Profile
✉ Email this page to a colleague
When do Exsel patents expire, and when can generic versions of Exsel launch?
Exsel is a drug marketed by Allergan Herbert and is included in one NDA.
The generic ingredient in EXSEL is selenium sulfide. There are eight drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the selenium sulfide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Exsel
A generic version of EXSEL was approved as selenium sulfide by PADAGIS US on January 10th, 1991.
Summary for EXSEL
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 40 |
Formulation / Manufacturing: | see details |
DailyMed Link: | EXSEL at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for EXSEL
US Patents and Regulatory Information for EXSEL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Allergan Herbert | EXSEL | selenium sulfide | LOTION/SHAMPOO;TOPICAL | 083892-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |